Utah Medical Products (UTMD) Gains from Investment Securities (2011 - 2025)
Utah Medical Products (UTMD) recorded quarterly Gains from Investment Securities of $121000.0 in Q4 2025, up 23.47% quarter-over-quarter from $98000.0 in Q4 2024, and up 23.47% on a YoY basis from $98000.0 in Q4 2024.
Utah Medical Products (UTMD) Gains from Investment Securities (2011 - 2025) Analysis & Trends
Utah Medical Products' Gains from Investment Securities history runs 15 years deep, the most recent figure standing at $121000.0 for Q4 2025.
- In Q4 2025, Gains from Investment Securities rose 23.47% year-over-year to $121000.0; the TTM figure through Dec 2025 stood at $121000.0 (up 23.47% YoY), while the FY2025 annual figure was $121000.0, up 23.47% from the prior year.
- Gains from Investment Securities was $121000.0 for Q4 2025 at Utah Medical Products, up from $98000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $121000.0 in Q4 2025 to a low of $52000.0 in Q4 2021.
- Historically, Gains from Investment Securities has averaged $84400.0 across 5 years, with a median of $84000.0 in 2023.
- The sharpest annual moves came in 2021 and 2022: Gains from Investment Securities fell 24.64% in 2021, then increased 28.85% in 2022.
- A 5-year view of Gains from Investment Securities shows it stood at $52000.0 in 2021, then gained by 28.85% to $67000.0 in 2022, then increased by 25.37% to $84000.0 in 2023, then gained by 16.67% to $98000.0 in 2024, then rose by 23.47% to $121000.0 in 2025.
- The last three Gains from Investment Securities figures came in at $121000.0 (Q4 2025), $98000.0 (Q4 2024), and $84000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Utah Medical Products | 216.87 Mn | 129.46 Mn | 5.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 121,000.00 |
| Dec 31, 2025 | 121,000.00 |
| Dec 31, 2024 | 98,000.00 |
| Dec 31, 2024 | 98,000.00 |
| Dec 31, 2023 | 84,000.00 |
| Dec 31, 2023 | 84,000.00 |
| Dec 31, 2022 | 67,000.00 |
| Dec 31, 2022 | 67,000.00 |
| Dec 31, 2021 | 52,000.00 |
| Dec 31, 2021 | 52,000.00 |
| Dec 31, 2020 | 69,000.00 |
| Dec 31, 2020 | 69,000.00 |
| Dec 31, 2019 | 52,000.00 |
| Dec 31, 2019 | 52,000.00 |
| Dec 31, 2018 | 61,000.00 |
| Dec 31, 2018 | 61,000.00 |
| Dec 31, 2017 | 54,000.00 |
| Dec 31, 2017 | 54,000.00 |
| Dec 31, 2016 | 75,000.00 |
| Dec 31, 2016 | 75,000.00 |